Catalyst Wire Dossier Catalyst Wire Dossier

Herpes Simplex Candidate Vaccine (gD2t) with Adjuvant

gD2t vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Herpes Simplex Candidate Vaccine (gD2t) with Adjuvant, covering 2008-06-17 to 2008-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects [Phase 3]

See pricing